With The American Health Care Act apparently stalled, Washington has seemingly moved on to other issues. That leaves doctors, insurers, drug companies, device manufacturers, employers, patients and consumers wondering what comes next for Obamacare, for President Trump and Congress and for the healthcare system.

Moderated by Al Jackson, Spectrum’s EVP of Public Affairs, the panel features commentary from key thinkers in Washington, D.C.:

Carol Kelly- Founder and Chief Executive Officer, Kelly Advocacy Outcomes
Carol has deep health policy expertise spanning both  government and the private sector, giving her an in-depth understanding of the issues and how they affect various healthcare stakeholders. Carol has been a leader with the Advanced Medical Technology Association (AdvaMed), the Centers for Medicare and Medicaid Services (CMS), the Department of Health and Human Services (HHS) and, most recently led the National Association of Chain Drug Stores’ Government Affairs and Public Policy group.

Dean Rosen- Partner, Mehlman Castagnetti Rosen & Thomas 
At Mehlman Castagnetti Rosen & Thomas, Dean has spent more than a decade representing major health systems, physician specialty organizations, private health plans, clinical laboratories, biopharmaceutical companies, trade associations and Fortune 500 companies seeking to impact national health policy, and make their voice heard among decision makers in Washington, D.C. Dean has worked in senior positions on both sides of the Capitol focusing specifically on health policy. A sought after speaker and commentator, he is considered one of the nation's leading experts in health policy and legislation.